Toggle Main Menu Toggle Search

Open Access padlockePrints

A successful collaboration between academia, biotech and pharma led to discovery of erdafitinib, a selective FGFR inhibitor recently approved by the FDA

Lookup NU author(s): Emeritus Professor Herbie Newell


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Publication metadata

Author(s): Murray CW, Newell DR, Angibaud P

Publication type: Editorial

Publication status: Published

Journal: MedChemComm

Year: 2019

Volume: 10

Issue: 9

Pages: 1509-1511

Online publication date: 30/08/2019

Acceptance date: 16/08/2019

ISSN (print): 2040-2503

ISSN (electronic): 2040-2511

Publisher: Royal Society of Chemistry


DOI: 10.1039/c9md90044f


Find at Newcastle University icon    Link to this publication